148 related articles for article (PubMed ID: 23913246)
1. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice.
Vagaja NN; Binz N; McLenachan S; Rakoczy EP; McMenamin PG
Br J Ophthalmol; 2013 Oct; 97(10):1343-50. PubMed ID: 23913246
[TBL] [Abstract][Full Text] [Related]
2. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
[TBL] [Abstract][Full Text] [Related]
3. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina.
McLenachan S; Chen X; McMenamin PG; Rakoczy EP
Clin Exp Ophthalmol; 2013 Aug; 41(6):582-92. PubMed ID: 23433122
[TBL] [Abstract][Full Text] [Related]
4. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
5. Changes in murine hyalocytes are valuable early indicators of ocular disease.
Vagaja NN; Chinnery HR; Binz N; Kezic JM; Rakoczy EP; McMenamin PG
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1445-51. PubMed ID: 22297487
[TBL] [Abstract][Full Text] [Related]
6. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2
Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315
[TBL] [Abstract][Full Text] [Related]
7. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes.
Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H
Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
Araújo RS; Silva MS; Santos DF; Silva GA
Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
[TBL] [Abstract][Full Text] [Related]
10. Detection of microvascular retinal changes in type I diabetic mice with optical coherence tomography angiography.
Uehara H; Lesuma T; Stocking P; Jensen N; Kumar SR; Zhang MA; Choi S; Zhang X; Archer B; Carroll L; Ambati BK
Exp Eye Res; 2019 Jan; 178():91-98. PubMed ID: 30268699
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice.
Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S
Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163
[TBL] [Abstract][Full Text] [Related]
12. The effects of age and Cx3cr1 deficiency on retinal microglia in the Ins2(Akita) diabetic mouse.
Kezic JM; Chen X; Rakoczy EP; McMenamin PG
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):854-63. PubMed ID: 23307960
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
14. Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic Retinopathy.
Bucolo C; Barbieri A; Viganò I; Marchesi N; Bandello F; Drago F; Govoni S; Zerbini G; Pascale A
Front Pharmacol; 2021; 12():707909. PubMed ID: 34489701
[TBL] [Abstract][Full Text] [Related]
15. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine.
Smith SB; Duplantier J; Dun Y; Mysona B; Roon P; Martin PM; Ganapathy V
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4154-61. PubMed ID: 18469181
[TBL] [Abstract][Full Text] [Related]
16. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
18. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2
Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H
Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085
[TBL] [Abstract][Full Text] [Related]
19. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
[TBL] [Abstract][Full Text] [Related]
20. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
